Shicong Huang

793 total citations
29 papers, 407 citations indexed

About

Shicong Huang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Shicong Huang has authored 29 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 9 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Shicong Huang's work include Respiratory Support and Mechanisms (11 papers), Natural product bioactivities and synthesis (7 papers) and Pharmacological Effects of Natural Compounds (6 papers). Shicong Huang is often cited by papers focused on Respiratory Support and Mechanisms (11 papers), Natural product bioactivities and synthesis (7 papers) and Pharmacological Effects of Natural Compounds (6 papers). Shicong Huang collaborates with scholars based in China, United Kingdom and Pakistan. Shicong Huang's co-authors include Jun Duan, Xiaoli Han, Linfu Bai, Lintong Zhou, Shuliang Guo, Wang Deng, Changyi Li, Chang Shu, Ying Zhao and Qi Li and has published in prestigious journals such as PLoS ONE, Molecules and Anesthesia & Analgesia.

In The Last Decade

Shicong Huang

24 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shicong Huang China 10 258 132 95 66 57 29 407
T. J. Trinder United Kingdom 9 268 1.0× 207 1.6× 87 0.9× 202 3.1× 18 0.3× 12 576
Régine Vermesch France 10 111 0.4× 80 0.6× 56 0.6× 118 1.8× 18 0.3× 13 393
P Auzépy France 9 139 0.5× 52 0.4× 90 0.9× 64 1.0× 16 0.3× 40 501
Masatoshi Uchida Japan 8 115 0.4× 91 0.7× 123 1.3× 40 0.6× 59 1.0× 15 418
O. Prakash Netherlands 11 106 0.4× 46 0.3× 44 0.5× 27 0.4× 59 1.0× 24 472
T Vassal France 7 58 0.2× 145 1.1× 90 0.9× 57 0.9× 35 0.6× 19 309
G. Kris Bysani United States 8 80 0.3× 29 0.2× 35 0.4× 73 1.1× 15 0.3× 10 300
Lorenz Weidhase Germany 11 145 0.6× 46 0.3× 125 1.3× 86 1.3× 9 0.2× 34 454
S. Pons Spain 12 192 0.7× 68 0.5× 64 0.7× 55 0.8× 29 0.5× 18 601
Jong Eun Park South Korea 10 57 0.2× 96 0.7× 65 0.7× 89 1.3× 29 0.5× 46 359

Countries citing papers authored by Shicong Huang

Since Specialization
Citations

This map shows the geographic impact of Shicong Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shicong Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shicong Huang more than expected).

Fields of papers citing papers by Shicong Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shicong Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shicong Huang. The network helps show where Shicong Huang may publish in the future.

Co-authorship network of co-authors of Shicong Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Shicong Huang. A scholar is included among the top collaborators of Shicong Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shicong Huang. Shicong Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Huang, Shicong, Guoqing Chen, Ning Na, et al.. (2025). Mechanisms of Zanthoxyli Pericarpium-Zingiberis Rhizoma in the Treatment of Gastric Cancer Based on Network Pharmacology and Experimental Validation. Drug Design Development and Therapy. Volume 19. 4537–4566.
3.
Chen, Guoqing, et al.. (2025). Review: performance of jujube and its extracts in cancer: therapeutic, toxicity-reducing and potentiating effects. Frontiers in Oncology. 15. 1489974–1489974. 1 indexed citations
4.
Na, Ning, Yi Nan, Guoqing Chen, et al.. (2024). Anti-Tumor Effects and Toxicity Reduction Mechanisms of Prunella vulgaris: A Comprehensive Review. Molecules. 29(8). 1843–1843. 5 indexed citations
6.
Na, Ning, et al.. (2024). Explore the mechanism of Astragalus membranaceus and Poria cocos drug pair in improving immunity based on network pharmacology. Medicine. 103(25). e38531–e38531. 1 indexed citations
7.
Chen, Hao, Xianzhe Tang, Yueye Huang, et al.. (2024). Remodel the perifollicular microenvironment via Minoxidil-loaded microneedle patch and cold atmospheric plasma for treating androgenetic alopecia. Nano Research. 17(7). 6411–6419. 8 indexed citations
8.
Na, Ning, Xiangyang Li, Yi Nan, et al.. (2024). Molecular mechanism of Saikosaponin-d in the treatment of gastric cancer based on network pharmacology and in vitro experimental verification. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(11). 8943–8959. 3 indexed citations
9.
Huang, Shicong, Yi Nan, Guoqing Chen, et al.. (2023). The Role and Mechanism of Perilla frutescens in Cancer Treatment. Molecules. 28(15). 5883–5883. 18 indexed citations
10.
Huang, Shicong, Yi Yang, Junfei Zhang, et al.. (2023). Exploring the molecular mechanism of glycyrrhetinic acid in the treatment of gastric cancer based on network pharmacology and experimental validation. Aging. 15(9). 3839–3856. 4 indexed citations
11.
Huang, Shicong, Guoqing Chen, Ning Na, et al.. (2023). Pharmacological Mechanisms and Adjuvant Properties of Licorice Glycyrrhiza in Treating Gastric Cancer. Molecules. 28(19). 6966–6966. 8 indexed citations
12.
Zhang, Rui, Linfu Bai, Xiaoli Han, et al.. (2021). Incidence, characteristics, and outcomes of delirium in patients with noninvasive ventilation: a prospective observational study. BMC Pulmonary Medicine. 21(1). 157–157. 16 indexed citations
13.
Duan, Jun, et al.. (2019). <p>Not All COPD Patients Benefit from Prophylactic Noninvasive Ventilation After Scheduled Extubation: An Exploratory Study</p>. International Journal of COPD. Volume 14. 2809–2814. 3 indexed citations
14.
Duan, Jun, Linfu Bai, Lintong Zhou, et al.. (2018). Resource use, characteristics and outcomes of prolonged non-invasive ventilation: a single-centre observational study in China. BMJ Open. 8(12). e019271–e019271. 4 indexed citations
15.
Duan, Jun, Linfu Bai, Lintong Zhou, Xiaoli Han, & Shicong Huang. (2018). Decreasing re-intubation using prophylactic noninvasive ventilation in elderly patients: A propensity-matched study. Journal of Critical Care. 50. 77–81. 3 indexed citations
16.
Jiang, Lei, Qingwu Jiang, Shicong Huang, et al.. (2018). GYY4137 attenuates LPS-induced acute lung injury via heme oxygenase-1 modulation. Pulmonary Pharmacology & Therapeutics. 54. 77–86. 25 indexed citations
17.
Duan, Jun, et al.. (2017). Noninvasive ventilation failure in pneumonia patients ≥ 65 years old: The role of cough strength. Journal of Critical Care. 44. 149–153. 3 indexed citations
18.
Duan, Jun, Xiaoli Han, Shicong Huang, & Linfu Bai. (2016). Noninvasive ventilation for avoidance of reintubation in patients with various cough strength. Critical Care. 20(1). 316–316. 20 indexed citations
19.
Duan, Jun, Xiaoli Han, Linfu Bai, Lintong Zhou, & Shicong Huang. (2016). Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients. Intensive Care Medicine. 43(2). 192–199. 160 indexed citations
20.
Duan, Jun, et al.. (2012). Protocol-directed versus physician-directed weaning from noninvasive ventilation. The Journal of Trauma: Injury, Infection, and Critical Care. 72(5). 1271–1275. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026